Adverse events appear to hold back positive Scholar Rock data; SanaCurrents closing out coverage
Scholar Rock Holding Corp. (NASDAQ:SRRK) reported positive topline data from [...]
Ionis’ Data in HAE Very Strong; SanaCurrents Closing Out Coverage
Ionis Pharmaceuticals, Inc., (NASDAQ:IONS) said on March 29 that its [...]
Marinus Pharma’s Epilepsy Drug Shows Promise; SanaCurrents Closing Out Coverage
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) disclosed results of its phase II [...]
SanaCurrents Discontinuing Coverage of Allogene (ALLO) Catalyst
Allogene Therapeutics (NASDAQ:ALLO) said last month it planned to release [...]
Anaptysbio Trial Fails To Meet Endpoint, SanaCurrents Closing Out Coverage
Before trading began on March 8, AnaptysBio (NASDAQ:ANAB) said top-line [...]
SanaCurrents Suspending Coverage of Immunovant (IMVT) Catalyst
Immunovant (NASDAQ:IMVT) said on February 16 it had begun to [...]
Immunovant Pauses Dosing in Trials; Elevated Cholesterol Not Measured Yet in WAIHA Trial
Immunovant (NASDAQ:IMVT) said Tuesday it had paused dosing patients in [...]
Turning Point Trial Records Positive Results; Matinas’ Drug Does Not Prove Superiority
Turning Point Therapeutics, Inc (NASDAQ:TPTX) said over the weekend that [...]